Mouse Plcd3 Conditional Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Plcd3 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Plcd3 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Plcd3 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Plcd3 gene (NCBI Reference Sequence: NM_152813 ; Ensembl: ENSMUSG00000020937 ) is located on Mouse chromosome 11. 15 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 15 (Transcript: ENSMUST00000103077). Exon 9~10 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Plcd3 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-133L3 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 9 starts from about 59.53% of the coding region. The knockout of Exon 9~10 will result in frameshift of the gene. The size of intron 8 for 5'-loxP site insertion: 1710 bp, and the size of intron 10 for 3'-loxP site insertion: 714 bp. The size of effective cKO region: ~945 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 8 9 10 11 15 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Plcd3 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7445bp) | A(22.28% 1659) | C(26.68% 1986) | T(23.99% 1786) | G(27.05% 2014) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 103075254 103078253 3000 browser details YourSeq 226 1711 2247 3000 83.5% chr2 + 91740324 91740679 356 browser details YourSeq 223 1737 2246 3000 90.0% chr2 - 168345659 168759129 413471 browser details YourSeq 210 1723 2245 3000 86.1% chr1 + 180731675 180731994 320 browser details YourSeq 202 1724 2245 3000 92.1% chr15 - 62021500 62100481 78982 browser details YourSeq 191 1725 2248 3000 84.7% chr19 + 37261667 37262172 506 browser details YourSeq 186 1741 2247 3000 83.4% chr16 - 13601716 13602076 361 browser details YourSeq 165 1710 2200 3000 88.5% chr19 - 6327806 6328291 486 browser details YourSeq 158 1737 2244 3000 87.0% chr4 + 150573348 150573690 343 browser details YourSeq 155 1710 2168 3000 92.4% chr4_JH584294_random + 123490 123986 497 browser details YourSeq 155 1710 2168 3000 92.4% chr4 + 42775695 42776191 497 browser details YourSeq 153 1710 1876 3000 96.5% chr7 - 16992964 16993134 171 browser details YourSeq 151 1714 1874 3000 97.6% chr11 - 100839190 100839390 201 browser details YourSeq 150 1711 1874 3000 96.4% chr12 - 112901126 112901293 168 browser details YourSeq 148 1701 1877 3000 92.6% chr14 - 101723493 101723692 200 browser details YourSeq 147 1710 1874 3000 93.9% chr3 - 9043126 9043289 164 browser details YourSeq 146 1715 1875 3000 94.3% chr4 - 124878490 124878647 158 browser details YourSeq 146 1710 1874 3000 94.6% chr2 - 136857315 136857480 166 browser details YourSeq 146 1710 1875 3000 95.1% chr2 + 137051929 137052098 170 browser details YourSeq 145 1706 1871 3000 95.7% chr17 + 29177381 29177548 168 Note: The 3000 bp section upstream of Exon 9 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 103071309 103074308 3000 browser details YourSeq 202 656 1162 3000 85.7% chr7 - 4908555 4908939 385 browser details YourSeq 190 652 1161 3000 83.4% chr6 - 31039839 31040173 335 browser details YourSeq 176 683 1162 3000 82.7% chr7 + 128758546 128758857 312 browser details YourSeq 172 654 850 3000 93.7% chr11 + 91299585 91299778 194 browser details YourSeq 169 652 1085 3000 83.6% chr13 - 74516466 74516752 287 browser details YourSeq 165 616 841 3000 87.6% chr5 - 23646718 23646925 208 browser details YourSeq 165 664 887 3000 93.7% chr9 + 92259533 92259778 246 browser details YourSeq 163 664 1162 3000 84.1% chr16 - 32308460 32308790 331 browser details YourSeq 162 659 846 3000 93.1% chr18 + 6460527 6460714 188 browser details YourSeq 158 656 850 3000 89.8% chr5 + 129944427 129944617 191 browser details YourSeq 156 658 841 3000 91.5% chr6 - 126796663 126796839 177 browser details YourSeq 156 664 1162 3000 80.6% chr7 + 3363066 3363342 277 browser details YourSeq 155 657 850 3000 89.1% chr17 - 27693535 27693721 187 browser details YourSeq 155 656 850 3000 91.9% chr14 - 54422598 54422794 197 browser details YourSeq 155 656 850 3000 90.2% chr9 + 62150487 62150678 192 browser details YourSeq 155 656 850 3000 91.8% chr12 + 111799790 111799983 194 browser details YourSeq 155 651 850 3000 89.4% chr10 + 120654797 120654993 197 browser details YourSeq 154 662 850 3000 93.3% chr13 - 42141636 42142003 368 browser details YourSeq 154 652 850 3000 91.4% chr5 + 23747035 23747238 204 Note: The 3000 bp section downstream of Exon 10 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Plcd3 phospholipase C, delta 3 [ Mus musculus (house mouse) ] Gene ID: 72469, updated on 10-Oct-2019 Gene summary Official Symbol Plcd3 provided by MGI Official Full Name phospholipase C, delta 3 provided by MGI Primary source MGI:MGI:107451 See related Ensembl:ENSMUSG00000020937 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as mKIAA1964; 2610205J15Rik Expression Broad expression in bladder adult (RPKM 8.4), stomach adult (RPKM 7.5) and 25 other tissues See more Orthologs human all Genomic context Location: 11 E1; 11 66.71 cM See Plcd3 in Genome Data Viewer Exon count: 18 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 11 NC_000077.6 (103070296..103101710, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 11 NC_000077.5 (102931610..102962972, complement) Chromosome 11 - NC_000077.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 5 transcripts Gene: Plcd3 ENSMUSG00000020937 Description phospholipase C, delta 3 [Source:MGI Symbol;Acc:MGI:107451] Gene Synonyms 2610205J15Rik Location Chromosome 11: 103,070,304-103,101,658 reverse strand. GRCm38:CM001004.2 About this gene This gene has 5 transcripts (splice variants), 263 orthologues, 14 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Plcd3-201 ENSMUST00000103077.1 3023 785aa ENSMUSP00000099366.1 Protein coding CCDS25512 Q8K2J0 TSL:1 GENCODE basic APPRIS P1 Plcd3-203 ENSMUST00000128650.7 1952 471aa ENSMUSP00000117455.1 Protein coding - F7AAE0 CDS 5' incomplete TSL:1 Plcd3-202 ENSMUST00000124740.1 591 No protein - lncRNA - - TSL:5 Plcd3-205 ENSMUST00000143012.1 509 No protein - lncRNA - - TSL:5 Plcd3-204 ENSMUST00000142970.1 425 No protein - lncRNA - - TSL:2 Page 6 of 8 https://www.alphaknockout.com 51.35 kb Forward strand 103.07Mb 103.08Mb 103.09Mb 103.10Mb 103.11Mb Genes Nmt1-201 >protein coding Acbd4-202 >nonsense mediated decay (Comprehensive set... Acbd4-205 >nonsense mediated decay Acbd4-203 >protein coding Acbd4-209 >protein coding Acbd4-206 >lncRNA Acbd4-201 >protein coding Acbd4-211 >retained intron Acbd4-207 >protein coding Acbd4-216 >retained intron Acbd4-208 >lncRNA Acbd4-214 >protein coding Acbd4-212 >retained intron Acbd4-210 >retained intron Acbd4-213 >retained intron Acbd4-215 >lncRNA Acbd4-204 >lncRNA Contigs AL731805.8 > Genes (Comprehensive set... < Plcd3-201protein coding < Plcd3-203protein coding < Plcd3-205lncRNA < Plcd3-202lncRNA < Plcd3-204lncRNA Regulatory Build 103.07Mb 103.08Mb 103.09Mb 103.10Mb 103.11Mb Reverse strand 51.35 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript RNA gene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000103077 < Plcd3-201protein coding Reverse strand 31.36 kb ENSMUSP00000099... MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) Superfamily SSF50729 EF-hand domain pair PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily SSF49562 SMART Pleckstrin homology domain Phosphatidylinositol-specific phospholipase
Recommended publications
  • Alopecia in a Viable Phospholipase C Delta 1 and Phospholipase C Delta 3 Double Mutant
    Alopecia in a Viable Phospholipase C Delta 1 and Phospholipase C Delta 3 Double Mutant Fabian Runkel1¤, Maik Hintze1,2, Sebastian Griesing1,2, Marion Michels1, Birgit Blanck1, Kiyoko Fukami3, Jean-Louis Gue´net4, Thomas Franz1* 1 Anatomisches Institut, Universita¨t Bonn, Bonn, Germany, 2 Studiengang Molekulare Biomedizin, LIMES, Bonn, Germany, 3 Laboratory of Genome and Biosignal, Tokyo University of Pharmacy and Life Science, Hachioji-city, Tokyo, Japan, 4 De´partement de Biologie du De´veloppement, Institut Pasteur, Paris, France Abstract Background: Inositol 1,4,5trisphosphate (IP3) and diacylglycerol (DAG) are important intracellular signalling molecules in various tissues. They are generated by the phospholipase C family of enzymes, of which phospholipase C delta (PLCD) forms one class. Studies with functional inactivation of Plcd isozyme encoding genes in mice have revealed that loss of both Plcd1 and Plcd3 causes early embryonic death. Inactivation of Plcd1 alone causes loss of hair (alopecia), whereas inactivation of Plcd3 alone has no apparent phenotypic effect. To investigate a possible synergy of Plcd1 and Plcd3 in postnatal mice, novel mutations of these genes compatible with life after birth need to be found. Methodology/Principal Findings: We characterise a novel mouse mutant with a spontaneously arisen mutation in Plcd3 (Plcd3mNab) that resulted from the insertion of an intracisternal A particle (IAP) into intron 2 of the Plcd3 gene. This mutation leads to the predominant expression of a truncated PLCD3 protein lacking the N-terminal PH domain. C3H mice that carry one or two mutant Plcd3mNab alleles are phenotypically normal. However, the presence of one Plcd3mNab allele exacerbates the alopecia caused by the loss of functional Plcd1 in Del(9)olt1Pas mutant mice with respect to the number of hair follicles affected and the body region involved.
    [Show full text]
  • The Protein Phosphatase PP2A Plays Multiple Roles in Plant Development by Regulation of Vesicle Traffic—Facts and Questions
    International Journal of Molecular Sciences Review The Protein Phosphatase PP2A Plays Multiple Roles in Plant Development by Regulation of Vesicle Traffic—Facts and Questions Csaba Máthé *, Márta M-Hamvas, Csongor Freytag and Tamás Garda Department of Botany, Faculty of Science and Technology, University of Debrecen, H-4032 Debrecen, Hungary; [email protected] (M.M.-H.); [email protected] (C.F.); [email protected] (T.G.) * Correspondence: [email protected] Abstract: The protein phosphatase PP2A is essential for the control of integrated eukaryotic cell functioning. Several cellular and developmental events, e.g., plant growth regulator (PGR) mediated signaling pathways are regulated by reversible phosphorylation of vesicle traffic proteins. Reviewing present knowledge on the relevant role of PP2A is timely. We discuss three aspects: (1) PP2A regulates microtubule-mediated vesicle delivery during cell plate assembly. PP2A dephosphorylates members of the microtubule associated protein family MAP65, promoting their binding to microtubules. Regulation of phosphatase activity leads to changes in microtubule organization, which affects vesicle traffic towards cell plate and vesicle fusion to build the new cell wall between dividing cells. (2) PP2A-mediated inhibition of target of rapamycin complex (TORC) dependent signaling pathways contributes to autophagy and this has possible connections to the brassinosteroid signaling pathway. (3) Transcytosis of vesicles transporting PIN auxin efflux carriers. PP2A regulates vesicle localization and recycling of PINs related to GNOM (a GTP–GDP exchange factor) mediated pathways. The proper intracellular traffic of PINs is essential for auxin distribution in the plant body, thus in whole Citation: Máthé, C.; M-Hamvas, M.; plant development.
    [Show full text]
  • Stimulation of Phospholipid Metabolism in Embryonic Muscle
    Proc. Natl. Acad. Sci. USA Vol. 76, No. 9, pp. 4474-4478, September 1979 Cell Biology Stimulation of phospholipid metabolism in embryonic muscle cells treated with phospholipase C (phospholipid synthesis/myogenesis) CLAUDIA KENT Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907 Communicated by Edwin T. Mertz, May 29, 1979 ABSTRACT Phospholipid metabolism is dramatically MATERIALS AND METHODS stimulated in cultured myogenic cells in which cell fusion was inhibited with phospholipase C (phosphatidylcholine choline- Cultured Cells. Pectoral muscle from 11-day chicken em- phosphohydrolase; EC 3.1.4.3). Phospholipase C was active bryos was dissected, loose connective tissue was removed, and under the culture conditions as shown by the degradation of the muscle was minced into 1- to 2-mm fragments. Cells were exogenous phosphatidylcholine. Rates of incorporation of 32p; dissociated from the tissue fragments by trituration with a and [metkyl-3Hlcholine into lipids were about 5-fold greater in phospholipase-treated cells than in either untreated fusing cells pasteur pipette (8) in calcium- and magnesium-free Earle's salt or untreated cells prevented from fusing by-calcium deprivation. solution. The cell suspension was filtered through cheesecloth, The greatest stimulation in the phospholipase C-treated cultures preplated for 15 min (9), and then diluted with culture medium occurred with synthesis of phospai tlcholine and sphin- to 5 X 105 cells/ml. The cells were plated in tissue culture dishes gomyelin; synthesis of phosphatidyinositol and cardiolipin was precoated with rat tail collagen (10) at 8 ml of cell suspension not stimulated. Degradation of cellular [32Plphosphatidylcholine and appearance in the culture medium of the degradation per 100 mm dish.
    [Show full text]
  • Emerging Roles of PHLPP Phosphatases in Cell Signaling
    PA61CH26_Newton ARjats.cls September 22, 2020 12:5 Annual Review of Pharmacology and Toxicology PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling Timothy R. Baffi,∗ Ksenya Cohen Katsenelson,∗ and Alexandra C. Newton Department of Pharmacology, University of California, San Diego, La Jolla, California 92093-0721, USA; email: [email protected] Annu. Rev. Pharmacol. Toxicol.2021. 61:26.1–26.21 Keywords The Annual Review of Pharmacology and Toxicology is PHLPP, Akt, PKC, phosphatase, phosphorylation, cancer, transcription online at pharmtox.annualreviews.org https://doi.org/10.1146/annurev-pharmtox-031820- Abstract 122108 Whereas protein kinases have been successfully targeted for a variety of dis- Copyright © 2021 by Annual Reviews. eases, protein phosphatases remain an underutilized therapeutic target, in All rights reserved part because of incomplete characterization of their effects on signaling net- ∗ These authors contributed equally to this article works. The pleckstrin homology domain leucine-rich repeat protein phos- Annu. Rev. Pharmacol. Toxicol. 2021.61. Downloaded from www.annualreviews.org phatase (PHLPP) is a relatively new player in the cell signaling field, and new Access provided by University of California - San Diego on 11/11/20. For personal use only. roles in controlling the balance among cell survival, proliferation, and apop- tosis are being increasingly identified. Originally characterized for its tumor- suppressive function in deactivating the prosurvival kinase Akt, PHLPP may have an opposing role in promoting survival, as recent evidence suggests. Additionally, identification of the transcription factor STAT1 as a substrate unveils a role for PHLPP as a critical mediator of transcriptional programs in cancer and the inflammatory response.
    [Show full text]
  • Mouse ENPP7 / NPP-7 Protein (His Tag)
    Mouse ENPP7 / NPP-7 Protein (His Tag) Catalog Number: 50567-M08H General Information SDS-PAGE: Gene Name Synonym: ALK-SMase; E-NPP7; NPP-7; NPP7; Alk-SMase; Gm254 Protein Construction: A DNA sequence encoding the mouse ENPP7 (Q3TIW9) (Met 1-Gln 421) was expressed, with a polyhistidine tag at the C-terminus. Source: Mouse Expression Host: Human Cells QC Testing Purity: > 90 % as determined by SDS-PAGE Endotoxin: Protein Description < 1.0 EU per μg of the protein as determined by the LAL method Mouse Ectonucleotide pyrophosphatase / phosphodiesterase family Stability: member 7, also known as Alkaline sphingomyelin phosphodiesterase, Intestinal alkaline sphingomyelinase, Alk-Smase, ENPP7 and NPP-7, is a Samples are stable for up to twelve months from date of receipt at -70 ℃ single-pass type I membrane protein which belongs to the nucleotide pyrophosphatase / phosphodiesterase family. ENPP7 / NPP-7 is Predicted N terminal: Ala 22 expressed in the intestines and human bile. ENPP7 / NPP-7 is localized at Molecular Mass: the surface of the microvillar membrane in small intestine enterocytes, as well as in endosome-like structures and in Golgi complex. The main The secreted recombinant mouse ENPP7 consists of 411 amino acids and function of ENPP7 / NPP-7 is to convert the dietary sphingomyelin into has a calculated molecular mass of 47 kDa. It migrates as an ceramide, the sphingolipid messengers via hydrolyzation. ENPP7 / NPP-7 approximately 60 kDa band in SDS-PAGE under reducing conditions due is also reported to exert a phospholipase C activity toward palmitoyl lyso- to glycosylation. phosphocholine. The activity of this enzyme is inhibited in a dose dependent manner by ATP, imidazole, orthovanadate and zinc ion.
    [Show full text]
  • PLCD3, a Flotillin2-Interacting Protein, Is Involved in Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells
    ONCOLOGY REPORTS 39: 45-52, 2018 PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells WeIDoNg LIu1,2*, XuXu LIu1,2*, LeI WANg1,2, BIN ZHu1,2, CHANG ZHANG1,2, WeI JIA1,2, HeCHeNg ZHu3, XINgDoNg LIu3, MeIZuo ZHoNg3, DAN XIE4, YANYu LIu1,2, SHASHA LI1,2, JIA SHI1,2, JIANXINg LIN1,2, XIAOMENG XIA5, XINgJuN JIANg6 and CAIPING REN1,2 1The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of education, Xiangya Hospital, Central South university, Changsha, Hunan 410008; 2Cancer Research Institute, Collaborative Innovation Center for Cancer Medicine, School of Basic Medical Science, Central South university, Changsha, Hunan 410078; 3Changsha Kexin Cancer Hospital, Changsha, Hunan 410205; 4State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen university Cancer Center, guangzhou, Hunan 510060; 5Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South university, Changsha, Hunan 410011; 6Department of Neurosurgery, Xiangya Hospital, Central South university, Changsha, Hunan 410008, P.R. China Received April 1, 2017; Accepted September 18, 2017 DoI: 10.3892/or.2017.6080 Abstract. Phospholipase C (PLC) is a pivotal enzyme in the tial of 5-8F, a highly metastatic NPC cell line, by restraining phosphoinositide pathway that promotes the second messen- its growth, proliferation, mobility and migration. The present gers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate study demonstrated that PLCD3 may be an oncogenic protein (IP3), to participate in eukaryotic signal transduction. Several in NPC and that it plays an important role in the progression PLC isozymes are associated with cancer, such as PLC-β1, of NPC partially by interacting with Flot2.
    [Show full text]
  • Activation of Mesangial Cells by the Phosphatase Inhibitor Vanadate
    Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy. U O Wenzel, … , G G Choudhury, H E Abboud J Clin Invest. 1995;95(3):1244-1252. https://doi.org/10.1172/JCI117774. Research Article The metalion vanadate has insulin-like effects and has been advocated for use in humans as a therapeutic modality for diabetes mellitus. However, since vanadate is a tyrosine phosphatase inhibitor, it may result in undesirable activation of target cells. We studied the effect of vanadate on human mesangial cells, an important target in diabetic nephropathy. Vanadate stimulated DNA synthesis and PDGF B chain gene expression. Vanadate also inhibited total tyrosine phosphatase activity and stimulated tyrosine phosphorylation of a set of cellular proteins. Two chemically and mechanistically dissimilar tyrosine kinase inhibitors, genistein and herbimycin A, blocked DNA synthesis induced by vanadate. Vanadate also stimulated phospholipase C and protein kinase C. Downregulation of protein kinase C abolished vanadate-induced DNA synthesis. Thus, vanadate-induced mitogenesis is dependent on tyrosine kinases and protein kinase C activation. The most likely mechanism for the effect of vanadate on these diverse processes involves the inhibition of cellular phosphotyrosine phosphatases. These studies demonstrating that vanadate activates mesangial cells may have major implications for the therapeutic potential of vanadate administration in diabetes. Although vanadate exerts beneficial insulin-like effects and potentiates the effect of insulin in sensitive tissue, it may result in undesirable activation of other target cells, such as mesangial cells. Find the latest version: https://jci.me/117774/pdf Activation of Mesangial Cells by the Phosphatase Inhibitor Vanadate Potential Implications for Diabetic Nephropathy Ulrich 0.
    [Show full text]
  • A Review of Phosphatidate Phosphatase Assays
    REVIEW A review of phosphatidate phosphatase assays Prabuddha Dey1, Gil-Soo Han1 , and George M. Carman1,* 1Department of Food Science and the Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, NJ, USA Abstract Phosphatidate phosphatase (PAP) catalyzes the ganisms studied thus far, PAP activity is dependent on the penultimate step in the synthesis of triacylglycerol and regu- DXDX(T/V) catalytic motif in the haloacid dehalogenase- lates the synthesis of membrane phospholipids. There is like domain (10, 13, 14). The enzyme is extensively modi- much interest in this enzyme because it controls the cellular fied posttranslationally by phosphorylation, which acutely levels of its substrate, phosphatidate (PA), and product, regulates its catalytic activity, subcellular localization, and DAG; defects in the metabolism of these lipid intermediates are the basis for lipid-based diseases such as obesity, lipodys- protein stability (15–17). Downloaded from trophy, and inflammation. The measurement of PAP activity is PAP is a key lipid metabolic enzyme that is required for required for studies aimed at understanding its mechanisms the synthesis of the neutral lipid triacylglycerol (TAG) and of action, how it is regulated, and for screening its activators major membrane phospholipids (16–18) (Fig. 1). The en- and/or inhibitors. Enzyme activity is determined through zyme product, DAG, is a direct precursor of TAG (16, 19–22), the use of radioactive and nonradioactive assays that measure whereas its substrate, PA, is a direct precursor of the lipo- the product, DAG, or Pi. However, sensitivity and ease of use nucleotide, CDP-DAG, a key intermediate in phospholipid www.jlr.org are variable across these methods.
    [Show full text]
  • The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling
    The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling Ahmed M. Abd-El-Haliem Thesis committee Promotor Prof. Dr P.J.G.M. de Wit Professor of Phytopathology Wageningen University Co-promotor Dr M.H.A.J. Joosten Associate professor, Laboratory of Phytopathology Wageningen University Other members Prof. Dr H.J. Bouwmeester, Wageningen University Prof. Dr M.W. Prins, University of Amsterdam Prof. Dr G.C. Angenent, Wageningen University Dr S.H.E.J. Gabriёls, Monsanto Holland BV, Wageningen This research was conducted under the auspices of the Graduate School of Experimental Plant Sciences. The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling Ahmed M. Abd-El-Haliem Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Thursday 23 October 2014 at 11.00 a.m. in the Aula. Ahmed M. Abd-El-Haliem The Role of Phosphatidylinositol-Specific Phospholipase-C in Plant Defense Signaling, 188 pages. PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN 978-94-6257-118-1 TABLE OF CONTENTS CHAPTER 1 General Introduction & Thesis Outline 7 CHAPTER 2 Identification of Tomato Phosphatidylinositol-Specific 19 Phospholipase-C (PI-PLC) Family Members and the Role of PLC4 and PLC6 in HR and Disease Resistance CHAPTER 3 Defense Activation
    [Show full text]
  • Human ENPP7 / NPP-7 Protein (His Tag)
    Human ENPP7 / NPP-7 Protein (His Tag) Catalog Number: 10885-H08H General Information SDS-PAGE: Gene Name Synonym: ALK-SMase; E-NPP7; NPP-7; NPP7 Protein Construction: A DNA sequence encoding the human ENPP7 (NP_848638.2) (Met 1-Ser 439) was fused with a C-terminal polyhistidine tag. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 95 % as determined by SDS-PAGE Endotoxin: Protein Description < 1.0 EU per μg of the protein as determined by the LAL method Ectonucleotide pyrophosphatase / phosphodiesterase family member 7, Stability: also known as Alkaline sphingomyelin phosphodiesterase, Intestinal alkaline sphingomyelinase, Alk-Smase, ENPP7 and NPP-7, is a single- ℃ Samples are stable for up to twelve months from date of receipt at -70 pass type I membrane protein which belongs to thenucleotide pyrophosphatase / phosphodiesterase family. ENPP7 / NPP-7 is Ala 22 Predicted N terminal: expressed in the intestines and human bile. ENPP7 / NPP-7 is localized at Molecular Mass: the surface of the microvillar membrane in small intestine enterocytes, as well as in endosome-like structures and in Golgi complex. The main The secreted recombinant human ENPP7 comprises 429 amino acids with function of ENPP7 / NPP-7 is to convert the dietary sphingomyelin into a predicted molecular mass of 49 kDa. As a result of glycosylation, rh ceramide, the sphingolipid messengers via hydrolyzation. ENPP7 / NPP-7 ENPP7 migrates as an approximately 55-60 kDa band in SDS-PAGE is also reported to exert a phospholipase C activity toward palmitoyl lyso- under reducing conditions. phosphocholine. The activity of this enzyme is inhibited in a dose dependent manner by ATP, imidazole, orthovanadate and zinc ion.
    [Show full text]
  • Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis
    biomolecules Review Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis Robert M. Schilke y, Cassidy M. R. Blackburn y , Temitayo T. Bamgbose and Matthew D. Woolard * Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA; [email protected] (R.M.S.); [email protected] (C.M.R.B.); [email protected] (T.T.B.) * Correspondence: [email protected]; Tel.: +1-(318)-675-4160 These authors contributed equally to this work. y Received: 12 September 2020; Accepted: 13 October 2020; Published: 15 October 2020 Abstract: Phospholipases are a family of lipid-altering enzymes that can either reduce or increase bioactive lipid levels. Bioactive lipids elicit signaling responses, activate transcription factors, promote G-coupled-protein activity, and modulate membrane fluidity, which mediates cellular function. Phospholipases and the bioactive lipids they produce are important regulators of immune cell activity, dictating both pro-inflammatory and pro-resolving activity. During atherosclerosis, pro-inflammatory and pro-resolving activities govern atherosclerosis progression and regression, respectively. This review will look at the interface of phospholipase activity, immune cell function, and atherosclerosis. Keywords: atherosclerosis; phospholipases; macrophages; T cells; lipins 1. Introduction All cellular membranes are composed mostly of phospholipids. Phospholipids are amphiphilic compounds with a hydrophilic, negatively charged phosphate group head and two hydrophobic fatty acid tail residues [1]. The glycerophospholipids, phospholipids with glycerol backbones, are the largest group of phospholipids, which are classified by the modification of the head group [1]. The negatively charged phosphate head forms an ionic bond with an amino alcohol. This bridges the glycerol backbone to the nitrogenous functional group (amino alcohol).
    [Show full text]
  • Glycerol Kinase Deficiency Alters Expression of Genes Involved in Lipid Metabolism, Carbohydrate Metabolism, and Insulin Signaling
    European Journal of Human Genetics (2007) 15, 646–657 & 2007 Nature Publishing Group All rights reserved 1018-4813/07 $30.00 www.nature.com/ejhg ARTICLE Glycerol kinase deficiency alters expression of genes involved in lipid metabolism, carbohydrate metabolism, and insulin signaling Lola Rahib1, Nicole K MacLennan2, Steve Horvath3,4, James C Liao5 and Katrina M Dipple*,1,2,4 1Biomedical Engineering, Interdepartmental Program, Henry Samueli School of Engineering and Applied Science at UCLA, Los Angeles, CA, USA; 2Department of Pediatrics and Mattel Children’s Hospital at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 3Department of Biostatistics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 4Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 5Department of Chemical and Biomolecular Engineering, Henry Samueli School of Engineering and Applied Science at UCLA, Los Angeles, CA, USA Glycerol kinase (GK) is at the interface of fat and carbohydrate metabolism and has been implicated in insulin resistance and type 2 diabetes mellitus. To define GK’s role in insulin resistance, we examined gene expression in brown adipose tissue in a glycerol kinase knockout (KO) mouse model using microarray analysis. Global gene expression profiles of KO mice were distinct from wild type with 668 differentially expressed genes. These include genes involved in lipid metabolism, carbohydrate metabolism, insulin signaling, and insulin resistance. Real-time polymerase chain reaction analysis confirmed the differential expression of selected genes involved in lipid and carbohydrate metabolism. PathwayAssist analysis confirmed direct and indirect connections between glycerol kinase and genes in lipid metabolism, carbohydrate metabolism, insulin signaling, and insulin resistance.
    [Show full text]